Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2026-01-22 @ 8:48 AM
Study NCT ID:
NCT00550069
Status:
UNKNOWN
Last Update Posted:
2007-12-27
First Post:
2007-10-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year
Sponsor:
Sheba Medical Center
Organization:
Study Overview
Official Title:
Late Preterm Infants:Clinical Course and Outcome From Birth Through Out the First Year of Life.
Status:
UNKNOWN
Status Verified Date:
2007-12
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Late preterm infants are at an increased risk for short and long term morbidity (during the 1st year of life, their neurodevelopmental status may also be delayed as compared to infants born at term). The term "near term infants" is probably a deceiving one.
Detailed Description:
The study will include all near term infants born at 3 Israeli medical centers during a one year period.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: